MoneyWorks4Me

Strides Pharma Scien - Quaterly Results

01 Nov 2025 Evaluate
The total revenue for the quarter ended September 2025 remained nearly unchanged at Rs. 5221.52 millions.Net profit for the quarter ended September 2025 increased significantly by 85.67% to Rs. 320.40 millions from Rs. 172.56 millions.The Operating Profit of the company witnessed a decrease to 763.15 millions from 789.12 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 5221.52 5195.48 0.50 10207.68 10325.48 -1.14 21394.23 18661.17 14.65
Other Income 140.92 235.47 -40.15 158.50 316.38 -49.90 461.88 587.11 -21.33
PBIDT 763.15 789.12 -3.29 1453.04 1520.51 -4.44 3086.30 2092.16 47.52
Interest 294.13 418.25 -29.68 598.61 823.38 -27.30 1459.12 1393.77 4.69
PBDT 469.02 370.77 26.50 854.43 697.03 22.58 1626.91 644.74 152.34
Depreciation 215.14 206.97 3.95 436.52 413.19 5.65 846.08 874.07 -3.20
PBT 253.88 163.80 54.99 417.91 283.84 47.23 780.83 -229.33 -440.48
TAX -66.52 -8.76 659.36 -35.96 2.94 -1323.13 189.27 13.42 1310.36
Deferred Tax 47.17 21.46 119.80 78.20 22.57 246.48 203.91 14.61 1295.69
PAT 320.40 172.56 85.67 453.87 280.90 61.58 591.56 -242.75 -343.69
Equity 921.73 919.58 0.23 921.73 919.58 0.23 921.63 919.00 0.29
PBIDTM(%) 14.62 15.19 -3.77 14.23 14.73 -3.33 14.43 11.21 28.67
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..